Grants and Contributions:
Title:
Assessment of RNA Disruption Using RNA Sequencing Technology
Agreement Number:
891559
Agreement Value:
$29,946.00
Agreement Date:
Aug 1, 2017 - Dec 31, 2018
Description:
This study will to investigate the feasibility of sequencing the major rRNAs in an RNA preparation using a nucleic acid sequencing technology in order to quantify the degree of rRNA fragmentation within the sample. RNA sequencing could then be used as a diagnostic tool to measure RNA disruption in samples taken from cancer patients during chemotherapy.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Toronto, Ontario, CA M5G 1L7
Reference Number:
172-2018-2019-Q2-891559
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
822107868
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 94 days.
Amendment Date
Aug 27, 2018
Recipient's Legal Name:
RNA Diagnostics Inc.
Federal Riding Name:
University--Rosedale
Federal Riding Number:
35110
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: